Moleculin Biotech News, Moleculin Biotech Quote, MBRX Quote

Moleculin Biotech (NQ:MBRX) Delayed: 2.19 +0.07 (3.30%)

Prev. Close

$2.12

Today 6M 1Y 5Y

Open

$2.14

52 Wk High

$9.58

52 Wk Low

$2.34

Day High

$2.26

Day Low

$2.09

P/E

N/A

EPS

$-0.34

Volume

110,270

Friends, Peers and Foes (?): AKTX, AMIX, CNSP, GRI, NUWE (more...)

ALERTS | RSS

Jul 6, 2026 08:33 AM Moleculin CEO discusses early MIRACLE trial data in investor segment
Jul 6, 2026 08:33 AM Moleculin CEO, Walter Klemp, Highlights Positive Preliminary MIRACLE Trial Results in Virtual Investor "What This Means" Segment
Jul 6, 2026 08:33 AM Moleculin CEO, Walter Klemp, Highlights Positive Preliminary MIRACLE Trial Results in Virtual Investor "What This Means" Segment
Jun 30, 2026 08:30 AM Form 8-K Moleculin Biotech, Inc. For: Jun 30
Jun 30, 2026 08:30 AM Form 8-K Moleculin Biotech, Inc. For: Jun 30
Jun 30, 2026 08:30 AM Moleculin reports interim AML trial data showing higher remission rates
Jun 30, 2026 08:30 AM Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
Jun 24, 2026 09:01 PM Form 4 Moleculin Biotech, Inc. For: Jun 20 Filed by: PICKER DONALD H
Jun 24, 2026 09:01 PM Form 4 Moleculin Biotech, Inc. For: Jun 20 Filed by: KLEMP WALTER V
Jun 24, 2026 09:00 PM Form 4 Moleculin Biotech, Inc. For: Jun 20 Filed by: Foster Jonathan P.

Entities mentioned with MBRX

View All Entities